PLURISTEM THERAPEUTICS INC's ticker is and the CUSIP is 72940R952. A total of 2 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $23,000 | -4.2% | 239 | -22.7% | 0.01% | +120.0% |
| Q4 2018 | $24,000 | -41.5% | 309 | -1.0% | 0.01% | 0.0% |
| Q3 2018 | $41,000 | +17.1% | 312 | +8.3% | 0.01% | 0.0% |
| Q2 2018 | $35,000 | +2.9% | 288 | +18.0% | 0.01% | +150.0% |
| Q1 2018 | $34,000 | -35.8% | 244 | -16.4% | 0.00% | 0.0% |
| Q3 2015 | $53,000 | -94.7% | 292 | -92.6% | 0.00% | -94.4% |
| Q2 2015 | $996,000 | +3.1% | 3,953 | +14.6% | 0.04% | -10.0% |
| Q1 2015 | $966,000 | +400.5% | 3,449 | +347.3% | 0.04% | +566.7% |
| Q4 2014 | $193,000 | -79.5% | 771 | -76.6% | 0.01% | -83.3% |
| Q3 2014 | $943,000 | -9.2% | 3,296 | -0.8% | 0.04% | -20.0% |
| Q2 2014 | $1,039,000 | -70.8% | 3,321 | -65.4% | 0.04% | -77.4% |
| Q1 2014 | $3,553,000 | +906.5% | 9,603 | +857.4% | 0.20% | +765.2% |
| Q4 2013 | $353,000 | +0.6% | 1,003 | -3.4% | 0.02% | 0.0% |
| Q3 2013 | $351,000 | – | 1,038 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 309 | $24,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |